高级搜索
干细胞因子Nanog在肿瘤中的研究进展[J]. 肿瘤防治研究, 2016, 43(4): 295-299. DOI: 10.3971/j.issn.1000-8578.2016.04.012
引用本文: 干细胞因子Nanog在肿瘤中的研究进展[J]. 肿瘤防治研究, 2016, 43(4): 295-299. DOI: 10.3971/j.issn.1000-8578.2016.04.012
Role of Nanog in Tumorigenesis and Tumor Development[J]. Cancer Research on Prevention and Treatment, 2016, 43(4): 295-299. DOI: 10.3971/j.issn.1000-8578.2016.04.012
Citation: Role of Nanog in Tumorigenesis and Tumor Development[J]. Cancer Research on Prevention and Treatment, 2016, 43(4): 295-299. DOI: 10.3971/j.issn.1000-8578.2016.04.012

干细胞因子Nanog在肿瘤中的研究进展

Role of Nanog in Tumorigenesis and Tumor Development

  • 摘要: Nanog是维持胚胎干细胞自我更新和多能性的关键转录因子。Nanog在分化的细胞中表达逐渐降低或缺失。研究发现肿瘤细胞中Nanog异常激活,并且与肿瘤发生、发展和转移密切相关。Nanog通过调控肿瘤细胞增殖、迁移和侵袭、肿瘤干性以及肿瘤免疫逃逸等多种机制参与肿瘤生长、转移和耐药。临床研究证据提示Nanog在肿瘤患者中异常高表达,可作为预后评估的独立指标。本文就Nanog在肿瘤中的作用、分子机制和临床应用的研究进展作一综述。

     

    Abstract: Nanog is a key transcription factor involved in maintaining the self-renewal and pluripotency of embryonic stem cells. The expression of Nanog is gradually decreased with cell differentiation and tissue maturation. The recent studies demonstrate that Nanog expression is restored in tumor cells. Nanog plays pleiotropic roles in tumorigenesis and tumor development. Nanog promotes tumor growth, metastasis and drug resistance via regulating tumor cell proliferation, migration and invasion, tumor stemness, as well as tumor immune escape. Nanog overexpression is an independent indicator for poor prognosis. In this review, we summarize the recent progress of Nanog in tumor and the underlying molecular mechanisms, with an emphasis on the potential of Nanog in tumor diagnosis and targeted therapy.

     

/

返回文章
返回